Therapy of patients with rheumatoid arthritis: Outcome of infliximab failures switched to etanercept-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapy of patients with rheumatoid arthritis: Outcome of infliximab failures switched to etanercept

Published:2007 Issue:3 Volume:57 Page:448-453
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Buch Maya H.,Bingham Sarah J.,Bejarano Victoria,Bryer Domini,White Jo,Emery Paul,Reece Richard,Quinn Mark

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference17 articles.

1. Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis

2. Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

3. Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

4. Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor blockers can make sense

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex vivo cell-based assay for assessment of response to TNF inhibitors in patients with rheumatic diseases;Rheumatology;2024-05-25

2. Does the Type of Failure and the Choice of the Second Biologic Influence Response and Persistence on Medication in Rheumatoid Arthritis?;JCR: Journal of Clinical Rheumatology;2023-08-24

3. TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond;Nature Reviews Rheumatology;2023-08-04

4. Toward Overcoming Treatment Failure in Rheumatoid Arthritis;Frontiers in Immunology;2021-12-23

5. Imidazolium-Based Ionic Liquid-Assisted Preparation of Nano-Spheres Loaded with Bio-Active Peptides to Decrease Inflammation in an Osteoarthritis Model: Ex Vivo Evaluations;Journal of Biomedical Nanotechnology;2021-05-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3